durvalumab
astrazeneca
['sclc', 'durvalumab', 'radio', 'nsclc', 'pacific']
durvalumab (durva) after chemoradiotherapy (crt) in unresectable, stage iii, egfr mutation-positive (egfrm) nsclc: a post hoc subgroup analysis from pacific. #asco22 repeat after me: immunotherapy in patients with egfrm stage iii nsclc is unclear 
Medicina Interna - Oncología Clínica - Profesor Titular @UPBColombia - Clínica Astorga. #Medellín / #Colombia mlujanonco@gmail.com #OncTwitter #Metaanalysis